Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ABT > SEC Filings for ABT > Form 8-K on 28-Mar-2014All Recent SEC Filings

Show all filings for ABBOTT LABORATORIES

Form 8-K for ABBOTT LABORATORIES


28-Mar-2014

Other Events, Financial Statements and Exhibits


Item 8.01 - Other Events

As previously disclosed in Abbott's 2013 Annual Report on Securities and Exchange Commission Form 10-K, seven shareholder derivative lawsuits have been pending in a consolidated proceeding, In Re Abbott-Depakote Shareholder Derivative Litigation, before the United States District Court for the Northern District of Illinois against certain of Abbott's current and former directors and members of senior management. An eighth shareholder derivative lawsuit was consolidated in In Re Abbott-Depakote Shareholder Derivative Litigation on March 12, 2014. On March 18, 2014, in connection with that consolidated proceeding, the court signed an "Order Preliminarily Approving Proposed Settlement, Directing The Issuance of Notice, And Setting A Final Settlement Hearing".

A copy of the Notice of Proposed Settlement of Consolidated Derivative Actions, Final Settlement Hearing, and Right to Appear is filed as Exhibit 99.1.



Item 9.01 - Financial Statements and Exhibits

Exhibit No.                                   Exhibit
99.1           Notice of Proposed Settlement of Consolidated Derivative Actions,
               Final Settlement Hearing, and Right to Appear

Private Securities Litigation Reform Act of 1995 - A Caution Concerning Forward-Looking Statements

Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors,'' to our Annual Report on Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2013, and are incorporated by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.


  Add ABT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ABT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.